Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
News207
Industry news, News 16/12/2021

Vaccine patent dispute emphasises the value of a robust IP portfolio

News206
News 09/12/2021

Pedalling through intellectual property space

News205
Events 17/11/2021

Secerna help ‘Seas the Day’ with rowing challenge sponsorship

B012939
Team news 03/11/2021

Secerna strengthens biotech team

B012668
Team news, Careers 12/10/2021

John Harbottle in profile

News204
Events 06/10/2021

Secerna set to attend NEPIC Conference on Digitalisation & Cyber Security

Cells
Events 05/10/2021

Biovale Workshop for Biological Enterprises

Plants 14.10.21
Industry news 01/10/2021

What the change in gene editing regulations means for IP in the UK

Dermot Roche Press 800X800px Colour Temp Pic
Events 22/09/2021

IPBC Europe: Leadership Summit

21 22 23 24 25 26 27 28 29 30 31